GILEAD SCIENCES, INC. Interest Payable, Current
GILEAD SCIENCES, INC. (GILD) had Interest Payable, Current of $210.00 million as of 2017-09-30, per its 10-Q filed 2017-11-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2017-11-07
- 2017-09-30: Interest Payable, Current $210.00M.
- 2017-06-30: Interest Payable, Current $298.00M.
- 2016-12-31: Interest Payable, Current $290.00M.
- 2015-12-31: Interest Payable, Current $232.00M.
| Period end | Interest Payable, Current |
|---|---|
| 2017-09-30 | $210.00M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $298.00M 10-Q · filed 2017-08-07 |
| 2016-12-31 | $290.00M 10-Q · filed 2017-11-07 |
| 2015-12-31 | $232.00M 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |